ENDP Stock: Endo International plc Stock Price, Analysis & Insights
Get live ENDP stock price $0.37, comprehensive Endo International plc stock analysis, charts, news, and expert forecast. Real-time ENDP stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Endo International plc operates as a specialty pharmaceutical firm, developing and marketing both proprietary brand-name and unbranded generic medications across the United States and global markets. Its Branded Pharmaceuticals division offers a dive...
Company Information
- CEO
- Blaise Coleman
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 3103
Contact Information
- Website
- https://www.endo.com
- Address
- Minerva House, Simmonscourt Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Endo International plc shareholders
- ⚠Market volatility can significantly impact stock price, especially for large-cap equities
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Endo International plc
- ⚠Investors should consider how Endo International plc fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
P/E Ratio (TTM)
-0.12
Beta
1.15
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare ENDP with peer companies:
- Price
- $1.29
- Market cap
- 64.44M
- Price
- $1.91
- Market cap
- 59.31M
- Price
- $15.31
- Market cap
- 499.50M
- Price
- $9.93
- Market cap
- 226.49M
- Price
- $4.11
- Market cap
- 71.52M
- Price
- $10.01
- Market cap
- 165.19K
- Price
- $0.94
- Market cap
- 5.22M
- Price
- $1.07
- Market cap
- 65.08M
- Price
- $0.76
- Market cap
- 61.46M
- Price
- $1.30
- Market cap
- 70.12M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.